Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls

Sponsor
Colorado State University (Other)
Overall Status
Completed
CT.gov ID
NCT02218138
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
35
1
2
43
0.8

Study Details

Study Description

Brief Summary

Type 2 diabetes is a chronic disease that puts people at risk for major health problems like heart disease. Type 2 diabetes is the most common type of diabetes in adults. However, there has been a concerning rise in type 2 diabetes among teenagers. Diabetes develops through poor insulin sensitivity, meaning that insulin - an important chemical the body makes to keep blood sugar normal - isn't working properly. Type 2 diabetes can be prevented by improving insulin sensitivity. Stress is related to insulin sensitivity. Individuals who feel stressed have worse insulin sensitivity than individuals who do not feel stressed. In adults, decreasing stress leads to improvements in insulin sensitivity, but this hasn't been tested in teenagers. The purpose of this study is to find out if taking part in a brief group program to decrease stress will improve insulin sensitivity and lower diabetes risk in teenage girls.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Learning 2 BREATHE
  • Behavioral: Colorado Blues
N/A

Detailed Description

After a screening to determine eligibility, girls are randomly assigned to take part in one of two 6-week group programs: 1) Learning to BREATHE - a mindfulness-based program, or 2) Colorado Blues - a cognitive-behavioral program. After the group, girls return for three follow-up visits over the course of a year. The main outcomes are depressive symptoms and insulin resistance. We also are assessing stress, eating behavior, fitness, and mindfulness.

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Depression and Insulin Resistance in Adolescents
Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Aug 1, 2016
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Learning 2 BREATHE

Learning 2 BREATHE, Mindfulness-based group program

Behavioral: Learning 2 BREATHE
Mindfulness-based group program

Experimental: Colorado Blues

Colorado Blues, Cognitive-behavioral depression prevention group

Behavioral: Colorado Blues
Colorado Blues, Cognitive-behavioral depression prevention group

Outcome Measures

Primary Outcome Measures

  1. Homeostasis model assessment of insulin resistance [1 year]

    Derived from fasting insulin and glucose

Secondary Outcome Measures

  1. Center for Epidemiological Studies-Depression Scale [1 year]

    Total sum score reflecting a continuous measure of depressive symptoms

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 17 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 12-17 years

  • Female

  • Overweight or obese, defined as a body mass index (BMI; kg/m2) ≥ 85th percentile for age

  • Family history of type 2 diabetes or pre-diabetes in 1st degree relative (e.g., parent or sibling) or 2nd degree relative (e.g., aunt, uncle, or grandparent)

  • Elevated stress/symptoms of depression as indicated by a Center for Epidemiological Studies-Depression Scale Total Score ≥ 16

  • Good general health as reported by adolescent and parent/guardian

  • English speaking (required for adolescent only, because the groups will be conducted in English)

Exclusion Criteria:
  • Pregnancy

  • Current psychiatric disorder such as major depressive disorder necessitating treatment

  • Type 2 diabetes as indicated by fasting glucose > 126 mg/dL

  • Use of medication affecting insulin resistance, body weight, or mood such as anti-depressants or stimulants

  • Current psychotherapy or weight loss treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Colorado State University Fort Collins Colorado United States 80523-1570

Sponsors and Collaborators

  • Colorado State University
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Lauren B Shomaker, PhD, Colorado State University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Colorado State University
ClinicalTrials.gov Identifier:
NCT02218138
Other Study ID Numbers:
  • 13-4265H
  • R00HD069516
First Posted:
Aug 15, 2014
Last Update Posted:
Mar 12, 2020
Last Verified:
Feb 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Colorado State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 12, 2020